Mounjaro and oral contraception: does GLP-1 reduce the pill's effectiveness?

The mechanism

GLP-1 receptor agonists — Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide) — slow gastric emptying. This is part of how they work for weight loss: food stays in the stomach longer, you feel full earlier, and you eat less. It is also how they cause the nausea most patients notice in the first weeks. The same delayed-emptying effect, however, applies to anything you swallow — including oral contraceptives.

The effect is largest during the first 4 weeks of treatment and during the weeks after every dose increase. As your body adapts, gastric emptying partly normalises, but the SmPC caution period remains formal.

What the Mounjaro SmPC actually says

The Eli Lilly Mounjaro SmPC advises patients taking combined oral contraceptives to:

• Use an additional non-oral method of contraception (typically a barrier method) for 4 weeks after starting Mounjaro AND for 4 weeks after each dose increase, OR
• Switch to a non-oral contraceptive method (coil, implant, depot injection, patch, ring) for the duration of treatment.

The 4-week rule applies after every dose-step (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) — meaning a patient escalating from 2.5 mg to 15 mg will pass through several 4-week back-up windows. For many women, the simpler answer is to switch to a non-oral method up front. We discuss this at the first appointment.

What is safer — non-oral methods

None of these methods rely on gastric absorption, so none are affected by delayed gastric emptying:

• Intrauterine device (IUD) — copper coil. Hormone-free, lasts 5–10 years depending on type.
• Intrauterine system (IUS) — hormonal coil (Mirena, Kyleena, Jaydess, Levosert). Lasts 3–8 years.
• Subdermal implant — Nexplanon. Lasts 3 years.
• Depot injection — medroxyprogesterone (Depo-Provera). Every 12–13 weeks.
• Transdermal patch — Evra. Weekly.
• Vaginal ring — NuvaRing. Monthly.

All of these are available via your GP, sexual health clinic or NHS LARC service. Switching is straightforward but does need a brief assessment.

What is still risky — oral methods

• Combined oral contraceptive pill (COC) — the standard combined pill. Absorption affected.
• Progestogen-only pill (POP, mini-pill) — Cerazette, Slynd and others. Absorption affected. The mini-pill is particularly time-sensitive, so any reduced absorption matters more.

If you stay on either of these, the 4-week back-up rule on starting and every dose step is the formal requirement.

Wegovy and Saxenda — same class, same caution

Both Wegovy (semaglutide) and Saxenda (liraglutide) carry similar warnings in their respective SmPCs. The mechanism — delayed gastric emptying — is the same across the GLP-1 receptor agonist class. The 4-week rule applies. See our Mounjaro vs Wegovy comparison for the broader class differences.

Pregnancy planning on Mounjaro

Mounjaro is not licensed for use in pregnancy. The SmPC advises stopping Mounjaro at least 1 month (4 weeks) before planned conception. Weight loss before conception has well-recognised fertility benefits — restored ovulation in PCOS, lower miscarriage risk, lower gestational diabetes risk — but the medication itself must be off-board before trying.

If you are planning pregnancy in the next few months, raise it at your monthly review. We will help plan a structured taper and the timing of stopping.

If you become pregnant on Mounjaro

This happens. The standard pathway:

• Stop Mounjaro immediately.
• Contact your GP for early pregnancy assessment and antenatal referral.
• The Mounjaro SmPC notes that human pregnancy data are limited, but to date there is no signal of major teratogenicity. Animal data showed some effects at high doses.
• Continue any prenatal vitamins (folic acid, vitamin D).
• We are happy to provide a written treatment record for your antenatal team.

The combined-pill plus GLP-1 plus first-trimester scenario

The most common version of this conversation looks like: a woman on the combined pill starts Mounjaro, the 4-week back-up rule is not followed, she becomes pregnant in the first cycle. We tell her: stop Mounjaro today, urgent GP referral, no need to panic about first-trimester teratogenicity based on current data, but ongoing pregnancy care is now the priority. The next conversation is about resuming weight loss treatment post-partum if appropriate.

The monthly review

Contraception is part of every Mounjaro monthly review at Trafford Clinic. We ask:

• Are you using contraception?
• What method?
• Are you within 4 weeks of starting or increasing a dose?
• Are you planning pregnancy in the next 12 months?

The conversation is brief, routine and not optional. It is the single most common drug interaction question in GLP-1 clinics. Related topics covered in monthly reviews include the side-effect timeline, the baseline blood panel, and the stopping Mounjaro picture.

Cross-cluster reading

For women with PCOS or hormonal symptoms relevant to GLP-1 treatment, our women's hormone panels guide covers cycle-day testing. The wider NICE CG189 BMI thresholds guide explains eligibility frameworks.

Local availability

Mounjaro treatment is available at Empire Pharmacy (GPhC premises 1123966), 122 Seymour Grove, Old Trafford. Patients book from across Greater Manchester — see local pages for Manchester, Rusholme, Sale and Altrincham. The brand weight loss service page sets out the broader programme.

If you are on the pill and considering Mounjaro, raise the contraception question at your first appointment. Call 0161 258 6149 or use our booking page.